{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Pittsburgh&page=41&state=Pennsylvania", "query": { "state": "Pennsylvania", "city": "Pittsburgh", "page": 41 }, "page_size": 10 }, "pagination": { "page": 41, "page_size": 10, "total_count": 10628, "total_pages": 1063, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Pittsburgh&page=42&state=Pennsylvania&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Pittsburgh&page=40&state=Pennsylvania&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T22:59:56.997Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03833167", "title": "Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Squamous Cell" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2019-04-01", "completion_date": "2026-01-20", "has_results": true, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 30, "location_summary": "Mobile, Alabama • Duarte, California • La Jolla, California + 26 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03833167" }, { "nct_id": "NCT03327519", "title": "Solving Insomnia Electronically: Sleep Treatment for Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma", "Insomnia" ], "interventions": [ { "name": "SHUTi", "type": "BEHAVIORAL" }, { "name": "Emmi", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 34, "start_date": "2018-05-29", "completion_date": "2022-08-15", "has_results": false, "last_update_posted_date": "2023-07-21", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03327519" }, { "nct_id": "NCT00952419", "title": "A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza", "Swine-origin A/H1N1 Influenza" ], "interventions": [ { "name": "Monovalent Subvirion A/H1N1 Influenza vaccine", "type": "BIOLOGICAL" }, { "name": "Normal saline solution (placebo)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "9 Years", "sex": "ALL", "summary": "6 Months to 9 Years" }, "enrollment_count": 474, "start_date": "2009-08", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 20, "location_summary": "Miami Beach, Florida • Marietta, Georgia • Woodstock, Georgia + 16 more", "locations": [ { "city": "Miami Beach", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Woodstock", "state": "Georgia" }, { "city": "Crestview Hills", "state": "Kentucky" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00952419" }, { "nct_id": "NCT07282600", "title": "A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1035, "start_date": "2025-12-15", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Cullman, Alabama • Tucson, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282600" }, { "nct_id": "NCT00428922", "title": "Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bhuvaneswari Ramaswamy", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2007-06-14", "completion_date": "2017-02-07", "has_results": true, "last_update_posted_date": "2018-08-09", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 3, "location_summary": "Cleveland, Ohio • Columbus, Ohio • Pittsburgh, Pennsylvania", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00428922" }, { "nct_id": "NCT00003775", "title": "Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain and Central Nervous System Tumors" ], "interventions": [ { "name": "leflunomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "1998-12", "completion_date": "2006-05", "has_results": false, "last_update_posted_date": "2012-09-13", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Los Angeles, California • Denver, Colorado + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003775" }, { "nct_id": "NCT04695977", "title": "CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Melanoma", "Advanced Melanoma", "Metastatic Melanoma", "Unresectable Melanoma" ], "interventions": [ { "name": "CMP-001", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2021-02-24", "completion_date": "2024-07-22", "has_results": true, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • La Jolla, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04695977" }, { "nct_id": "NCT05017701", "title": "Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Bridge device", "type": "DEVICE" }, { "name": "Sham device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Masimo Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2022-04-26", "completion_date": "2023-05-24", "has_results": true, "last_update_posted_date": "2025-10-21", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05017701" }, { "nct_id": "NCT00260572", "title": "Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gastroesophageal Reflux Disease" ], "interventions": [ { "name": "Questionnaires to evaluate QOL", "type": "BEHAVIORAL" }, { "name": "Questionnaires to evaluate heartburn and quality of life", "type": "BEHAVIORAL" }, { "name": "Questionnaire to evaluate satisfaction with treatment", "type": "BEHAVIORAL" }, { "name": "Questionnaire to evaluate presence or absence of pain", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2500, "start_date": "1999-04", "completion_date": "2050-12", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00260572" }, { "nct_id": "NCT03507777", "title": "ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Coronary Stenosis", "Atherosclerosis", "STEMI", "STEMI - ST Elevation Myocardial Infarction", "NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)" ], "interventions": [ { "name": "Coronary PCI guided by OCT", "type": "DEVICE" }, { "name": "Coronary PCI guided by Angiography", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2487, "start_date": "2018-05-17", "completion_date": "2023-02-28", "has_results": true, "last_update_posted_date": "2024-08-01", "last_synced_at": "2026-11-09T22:59:56.997Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Burlingame, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Burlingame", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03507777" } ] }